Dr. Jeffrey Kalmut, a fellow at the American Society of Addiction Medicine, presents "Safety Issues and Cardiac Side-Effects in the Administration of Ibogaine HCl, as an Addiction Interrupter Drug. What we know, what we theorize and what we don't know." This presentation was given at the 2009 Drug Policy Alliance Conference in Albuquerque, New Mexico.